Wine consumption and renal diseases: new perspectives

Nutrition

Volumn 23, Issue 7-8, 2007, Pages 598-602

  Lo Presti, Rosalia ^a   Carollo, Caterina ^a   Caimi, Gregorio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Chronic renal failure; Ethanol; Oxidative stress; Vascular endothelium; Wine

Indexed keywords

ALCOHOL; POLYPHENOL;

ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERTENSION; KIDNEY ISCHEMIA; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RED WINE; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; WINE;

ANTIOXIDANTS; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENOLS; WINE;

EID: 34347261017     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.04.012     Document Type: Review

References (61)

1. Locatelli F., Pozzoni P., Tentori F., and del Vecchio L. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant 18 suppl 7 (2003) 2-9
2. Rodrigo R., and Rivera G. Renal damage mediated by oxidative stress. A hypothesis of protective effects of red wine. Free Radic Biol Med 33 (2002) 409-422
3. Annuk M., Zilmer M., and Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease. Kidney Int 63 suppl 84 (2003) S50-S53
4. Galle J., and Wanner C. Oxidative stress and vascular injury-relevant for atherogenesis in uraemic patients?. Nephrol Dial Transplant 12 (1997) 2480-2483
5. Sharma R., Khanna A., Sharma M., and Savin V.J. Transforming growth factor-beta1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals. Kidney Int 58 (2000) 131-136
6. Klahr S., and Morrissey J.J. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int 75 suppl (2000) S7-S14
7. Li X., Kimura H., Hirota K., Kasuno K., Torii K., Okada T., et al. Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells. Kidney Int 68 (2005) 569-583
8. Kimura H. Increased expression of plasminogen activator inhibitor-1 in hypoxic renal injury and its pathological significance in progression of advanced renal disease. Rinsho Byori 53 (2005) 749-758
9. Baldwin Jr. A.S. The transcription factor NF-kB and human disease. J Clin Invest 107 (2001) 3-6
10. Chang J.W., Kim C.S., Kim S.B., Park S.K., Park J.S., and Lee S.K. Proinflammatory cytokine-induced NF-kappaB activation in human mesangial cells is mediated through intracellular calcium but not ROS: effects of silymarin. Nephron Exp Nephrol 103 (2006) e156-e165
11. Kitamura M., and Ishikawa Y. Oxidant-induced apoptosis of glomerular cells: intracellular signaling and its intervention by bioflavonoid. Kidney Int 56 (1999) 1223-1229
12. Dogra G., Ward N., Croft K.D., et al. Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential. Nephrol Dial Transplant 16 (2001) 1626-1630
13. Dogra G.K., Herrmann S., Irish A.B., Thomas M.A., and Watts G.F. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 17 (2002) 2220-2225
14. Galle J., and Wanner C. Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation. Miner Electrolyte Metab 25 (1999) 263-268
15. Galle J., Heinloth A., Wanner C., and Heermeier K. Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress. Kidney Int 78 suppl (2001) S120-S123
16. Pal S., Ho S.S., and Takechi R. Red wine polyphenols suppress the secretion of ApoB48 from human intestinal CaCo-2 cells. J Agric Food Chem 53 (2005) 2767-2772
17. Scott R.B., Reddy K.S., Husain K., Schlorff E.C., Rybak L.P., and Somani S.M. Dose response of ethanol on antioxidant defense system of liver, lung, and kidney in rat. Pathophysiology 7 (2000) 25-32
18. Orellana M., Valdes E., Fernandez J., and Rodrigo R. Effects of chronic ethanol consumption on extramitochondrial fatty acid oxidation and ethanol metabolism by rat kidney. Gen Pharmacol 30 (1998) 719-723
19. Dreosti I.E., Manuel S.J., and Buckley R.A. Superoxide dismutase (EC 1.15.1.1), manganese and the effect of ethanol in adult and foetal rats. Br J Nutr 48 (1982) 205-210
20. Rodrigo R., Rivera G., Orellana M., Araya J., and Bosco C. Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Life Sci 71 (2002) 2881-2895
21. Peters H., Martini S., Woydt R., et al. Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis. Am J Physiol Renal Physiol 284 (2003) F1105-F1114
22. Cecchin E., and De Marchi S. Alcohol misuse and renal damage. Addict Biol 1 (1996) 7-17
23. Husain K., Scott B.R., Reddy S.K., and Somani S.M. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol 25 (2001) 89-97
24. Volpato S., Pahor M., Ferrucci L., et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults. Circulation 109 (2004) 607-612
25. Di Castelnuovo A., Rotondo S., Iacoviello L., Donati M.B., and De Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105 (2002) 2836-2844
26. Böhm M., Rosenkranz S., and Laufs U. Alcohol and red wine: impact on cardiovascular risk. Nephrol Dial Transplant 19 (2004) 11-16
27. Rimm E.B., and Stampfer M.J. Wine, beer and spirits: are they really horses of a different color?. Circulation 105 (2002) 2806-2807
28. Tsang C., Higgins S., Duthie G.G., Duthie S.J., Howie M., Mullen W., et al. The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers. Br J Nutr 93 (2005) 233-240
29. McCann S.E., Sempos C., Freudenheim J.L., et al. Alcoholic beverage preference and characteristics of drinkers and nondrinkers in western New York (United States). Nutr Metab Cardiovasc Dis 13 (2003) 2-11
30. Corder R., Mullen W., Khan N.H., Marks S.C., Wood E.G., Carrier M.J., and Crozier A. Oenology: red wine procyanidins and vascular health. Nature 444 7119 (2006) 566
31. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72 (2003) 2219-2233
32. Leiro J., Arranza J.A., Fraiz N., Sanmartin M.L., Quezada E., and Orallo F. Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling. Int Immunopharmacol 5 (2005) 393-406
33. Sevov M., Elfineh L., and Cavelier L.B. Resveratrol regulates the expression of LXR-α in human macrophages. Biochem Biophys Res Commun 348 (2006) 1047-1054
34. Brito P.M., Mariano A., Almeida L.M., and Dinis T.C.P. Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: a role for intracellular glutathione. Chem Biol Interact 164 (2006) 157-166
35. Ou H.C., Chou F.P., Sheen H.M., Lin T.M., Yang C.H., and Sheu W.H.H. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Chim Acta 364 (2006) 196-204
36. Chun Y.J., Kim M.Y., and Guengerich F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262 (1999) 20-24
37. Orellana M., Araya J., Guajardo V., and Rodrigo R. Modulation of cytochrome P450 activity in the kidney of rats following long-term red wine exposure. Comp Biochem Physiol C 132 (2002) 399-405
38. Nihei T., Miura Y., and Yagasaki K. Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats. Life Sci 68 (2001) 2845-2852
39. Ha H., and Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 51 suppl (1995) S18-S21
40. Anjaneyulu M., and Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 21 (2004) 244-248
41. Chander V., and Chopra K. Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg 42 (2005) 1198-1205
42. Buffoli B., Pechanovà O., Kojsovà S., Andriantsitohaina R., Giugno L., Bianchi R., and Rezzani R. Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression. J Histochem Cytochem 53 (2005) 1459-1468
43. Facchini F.S., and Saylor K.L. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes 52 (2003) 1204-1209
44. Ishikawa Y., and Kitamura M. Bioflavonoid quercetin inhibits mitosis and apoptosis of glomerular cells in vitro and in vivo. Biochem Biophys Res Commun 279 (2000) 629-634
45. Satyanarayana P.S., Singh D., and Chopra K. Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats. Methods Find Exp Clin Pharmacol 23 (2001) 175-181
46. Krajka-Kuzniak V., and Baer-Dubowska W. The effects of tannic acid on cytochrome P450 and phase II enzymes in mouse liver and kidney. Toxicol Lett 143 (2003) 209-216
47. Shaohua S., Shusen Z., Youfa Z., Changku J., and Haiyang X. Inhibitory effect of tea polyphenols on renal cell apoptosis in rat test subjects suffering from cyclosporine-induced chronic nephrotoxicity. Chin Med J 116 (2003) 1345-1350
48. Hemmesrtone J.F., Lazarus S.A., and Schmitz H.H. Procyanidin content and variation in some commonly consumed foods. J Nutr 130 (2000) 2086S92
49. Giovannini L., Migliori M., Longoni B.M., et al. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 37 (2001) 262-270
50. Kahraman A., Erkasap N., Serteser M., and Koken T. Protective effect of quercetin on renal ischemia/reperfusion injury in rats. J Nephrol 16 (2003) 219-224
51. Bertelli A.A., Migliori M., Panichi V., et al. Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann N Y Acad Sci 957 (2002) 230-238
52. Shigematsu S., Ishida S., Hara M., et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 34 (2003) 810-817
53. Bertelli A.A., Migliori M., Filippi C., et al. Effect of ethanol and red wine on ochratoxin A-induced experimental acute nephrotoxicity. J Agric Food Chem 53 (2005) 6924-6929
54. Corrao G., Bagnardi V., Zambon A., and La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38 (2004) 613-619
55. Renaud S.C., Gueguen R., Conard P., Lanzmann-Petithory D., Orgogozo J.M., and Henry O. Moderate wine drinkers have lower hypertension-related mortality: a prospective cohort study in French men. Am J Clin Nutr 80 (2004) 621-625
56. Rodrigo R., and Thielemann L. Effects of chronic and acute ethanol exposure on renal (Na+K)-ATPase in the rat. Gen Pharmacol 29 (1997) 719-723
57. Aoi W., Niisato N., Miyazaki H., and Marunaka Y. Flavonoid-induced reduction of ENaC expression in the kidney of Dahl salt-sensitive hypertensive rats. Biochem Biophys Res Commun 315 (2004) 892-896
58. Fitzpatrick D.F., Hirschfield S.L., and Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265 (1993) H774-H778
59. Andriambeloson E., Kleschyov A.L., Muller B., Beretz A., Stoclet J.C., and Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol 120 (1997) 1053-1058
60. Duarte J., Pérez-Palencia R., Vargas F., et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 133 (2001) 117-124
61. Bagi Z., Hamar P., Antus B., Rosivall L., and Koller A. Chronic renal failure leads to reduced flow-dependent dilation in isolated rat skeletal muscle arterioles due to lack of NO mediation. Kidney Blood Press Res 26 (2003) 19-26